{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:02:29Z","timestamp":1771545749561,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jiangxi Provincial Academic and Technical Leader Training Program in Major Disciplines","award":["20225BCJ22009"],"award-info":[{"award-number":["20225BCJ22009"]}]},{"name":"Jiangxi Provincial Health Commission project","award":["202610361"],"award-info":[{"award-number":["202610361"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15554-w","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:53:44Z","timestamp":1768791224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretable machine learning using CT radiomics predicts pathological upgrading after secondary resection in non-muscle-invasive bladder cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Xue Peng","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin Chang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan Jiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai Chao","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian Biao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,19]]},"reference":[{"key":"15554_CR1","doi-asserted-by":"publisher","unstructured":"Dyrskj\u00f8t L, Hansel DE, Efstathiou JA et al. Bladder cancer. Nat Rev Dis Primers. 2023;9(1):58. Published 2023 Oct 26. https:\/\/doi.org\/10.1038\/s41572-023-00468-9.","DOI":"10.1038\/s41572-023-00468-9"},{"key":"15554_CR2","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, et al. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743. https:\/\/doi.org\/10.1136\/bmj-2023-076743. Published 2024 Feb 12.","journal-title":"BMJ"},{"issue":"19","key":"15554_CR3","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, et al. Bladder cancer: A review. JAMA. 2020;324(19):1980\u201391. https:\/\/doi.org\/10.1001\/jama.2020.17598.","journal-title":"JAMA"},{"issue":"1","key":"15554_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, et al. European association of urology guidelines on Non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in Situ). Eur Urol. 2022;81(1):75\u201394. https:\/\/doi.org\/10.1016\/j.eururo.2021.08.010.","journal-title":"Eur Urol"},{"issue":"1","key":"15554_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejso.2022.06.005","volume":"49","author":"L Lin","year":"2023","unstructured":"Lin L, Guo X, Ma Y, et al. Does repeat transurethral resection of bladder tumor influence the diagnosis and prognosis of T1 bladder cancer? A systematic review and meta-analysis. Eur J Surg Oncol. 2023;49(1):29\u201338. https:\/\/doi.org\/10.1016\/j.ejso.2022.06.005.","journal-title":"Eur J Surg Oncol"},{"key":"15554_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.euros.2025.10.017","volume":"82","author":"M Finati","year":"2025","unstructured":"Finati M, Schiavone N, Barone B, et al. Refining active surveillance eligibility in Intermediate-risk Non-muscle-invasive bladder cancer: the impact of time to first recurrence. Eur Urol Open Sci. 2025;82:155\u20139. https:\/\/doi.org\/10.1016\/j.euros.2025.10.017. Published 2025 Nov 7.","journal-title":"Eur Urol Open Sci"},{"key":"15554_CR7","doi-asserted-by":"publisher","first-page":"175883592412984","DOI":"10.1177\/17588359241298470","volume":"16","author":"QX Yu","year":"2024","unstructured":"Yu QX, Wu RC, Tuo ZT, et al. Role of repeat transurethral resection in no-muscle-invasive bladder tumour: an umbrella review. Ther Adv Med Oncol. 2024;16:17588359241298470. https:\/\/doi.org\/10.1177\/17588359241298470. Published 2024 Nov 16.","journal-title":"Ther Adv Med Oncol"},{"issue":"2","key":"15554_CR8","doi-asserted-by":"publisher","first-page":"e2408069","DOI":"10.1002\/advs.202408069","volume":"12","author":"Y Guo","year":"2025","unstructured":"Guo Y, Li T, Gong B, et al. From images to genes: radiogenomics based on artificial intelligence to achieve Non-Invasive precision medicine in cancer patients. Adv Sci (Weinh). 2025;12(2):e2408069. https:\/\/doi.org\/10.1002\/advs.202408069.","journal-title":"Adv Sci (Weinh)"},{"key":"15554_CR9","doi-asserted-by":"publisher","unstructured":"Zhang YP, Zhang XY, Cheng YT et al. Artificial intelligence-driven radiomics study in cancer: the role of feature engineering and modeling. Mil Med Res. 2023;10(1):22. Published 2023 May 16. https:\/\/doi.org\/10.1186\/s40779-023-00458-8.","DOI":"10.1186\/s40779-023-00458-8"},{"issue":"1","key":"15554_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.semradonc.2022.10.009","volume":"33","author":"NS Moore","year":"2023","unstructured":"Moore NS, McWilliam A, Aneja S. Bladder cancer radiation oncology of the future: prognostic Modelling, Radiomics, and treatment planning with artificial intelligence. Semin Radiat Oncol. 2023;33(1):70\u20135. https:\/\/doi.org\/10.1016\/j.semradonc.2022.10.009.","journal-title":"Semin Radiat Oncol"},{"issue":"12","key":"15554_CR11","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3390\/cancers14122860","volume":"14","author":"S Saxena","year":"2022","unstructured":"Saxena S, Jena B, Gupta N, et al. Role of artificial intelligence in radiogenomics for cancers in the era of precision medicine. Cancers (Basel). 2022;14(12):2860. https:\/\/doi.org\/10.3390\/cancers14122860. Published 2022 Jun 9.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"15554_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/jmri.28498","volume":"58","author":"L Zhang","year":"2023","unstructured":"Zhang L, Li X, Yang L, et al. Multi-Sequence and Multi-Regional MRI-Based radiomics nomogram for the preoperative assessment of muscle invasion in bladder cancer. J Magn Reson Imaging. 2023;58(1):258\u201369. https:\/\/doi.org\/10.1002\/jmri.28498.","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"15554_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40644-023-00609-z","volume":"23","author":"H Song","year":"2023","unstructured":"Song H, Yang S, Yu B, et al. CT-based deep learning radiomics nomogram for the prediction of pathological grade in bladder cancer: a multicenter study. Cancer Imaging. 2023;23(1):89. https:\/\/doi.org\/10.1186\/s40644-023-00609-z. Published 2023 Sep 18.","journal-title":"Cancer Imaging"},{"issue":"7","key":"15554_CR14","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1007\/s00261-024-04748-0","volume":"50","author":"T Zhao","year":"2025","unstructured":"Zhao T, He J, Zhang L, et al. A multimodal deep-learning model based on multichannel CT radiomics for predicting pathological grade of bladder cancer. Abdom Radiol (NY). 2025;50(7):3049\u201359. https:\/\/doi.org\/10.1007\/s00261-024-04748-0.","journal-title":"Abdom Radiol (NY)"},{"key":"15554_CR15","doi-asserted-by":"publisher","unstructured":"Wang Z, Shi H, Wang Q, et al. AI-driven and traditional radiomic model for predicting muscle invasion in bladder cancer via Multi-parametric imaging: A systematic review and Meta-analysis. Acad radiol. Published Online September. 2025;5. https:\/\/doi.org\/10.1016\/j.acra.2025.08.035.","DOI":"10.1016\/j.acra.2025.08.035"},{"issue":"8","key":"15554_CR16","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/medicina57080749","volume":"57","author":"J Dobruch","year":"2021","unstructured":"Dobruch J, Oszczud\u0142owski M. Bladder cancer: current challenges and future directions. Med (Kaunas). 2021;57(8):749. https:\/\/doi.org\/10.3390\/medicina57080749. Published 2021 Jul 24.","journal-title":"Med (Kaunas)"},{"issue":"6","key":"15554_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, et al. Epidemiology, Screening, and prevention of bladder cancer. Eur Urol Oncol. 2022;5(6):628\u201339. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003.","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"15554_CR18","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.euf.2021.06.007","volume":"8","author":"S Ourfali","year":"2022","unstructured":"Ourfali S, Matillon X, Ricci E, et al. Prognostic implications of treatment delays for patients with Non-muscle-invasive bladder cancer. Eur Urol Focus. 2022;8(5):1226\u201337. https:\/\/doi.org\/10.1016\/j.euf.2021.06.007.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"15554_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.euf.2023.07.002","volume":"10","author":"T Yanagisawa","year":"2024","unstructured":"Yanagisawa T, Kawada T, von Deimling M, et al. Repeat transurethral resection for Non-muscle-invasive bladder cancer: an updated systematic review and Meta-analysis in the contemporary era. Eur Urol Focus. 2024;10(1):41\u201356. https:\/\/doi.org\/10.1016\/j.euf.2023.07.002.","journal-title":"Eur Urol Focus"},{"key":"15554_CR20","doi-asserted-by":"publisher","unstructured":"Guigui A, Basile G, Zattoni F et al. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer. World J Urol. 2024;42(1):480. Published 2024 Aug 12. https:\/\/doi.org\/10.1007\/s00345-024-05192-x.","DOI":"10.1007\/s00345-024-05192-x"},{"issue":"10","key":"15554_CR21","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.ejso.2021.05.007","volume":"47","author":"A Minervini","year":"2021","unstructured":"Minervini A, Di Maida F, Tasso G, et al. Robot assisted radical cystectomy with Florence robotic intracorporeal neobladder (FloRIN): analysis of survival and functional outcomes after first 100 consecutive patients upon accomplishment of phase 3 IDEAL framework. Eur J Surg Oncol. 2021;47(10):2651\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2021.05.007.","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"15554_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s11255-020-02772-9","volume":"53","author":"M Yasui","year":"2021","unstructured":"Yasui M, Ohta JI, Aoki S, et al. Prognosis of patients with T1 bladder cancer after En bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa. Int Urol Nephrol. 2021;53(6):1105\u20139. https:\/\/doi.org\/10.1007\/s11255-020-02772-9.","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"15554_CR23","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1080\/08941939.2021.2017080","volume":"35","author":"J Pi","year":"2022","unstructured":"Pi J, Xiong Y, Liu C, et al. A nomogram model to predict recurrence of Non-Muscle invasive bladder urothelial carcinoma after resection based on clinical parameters and immunohistochemical markers. J Invest Surg. 2022;35(5):1186\u201394. https:\/\/doi.org\/10.1080\/08941939.2021.2017080.","journal-title":"J Invest Surg"},{"issue":"3","key":"15554_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.urolonc.2021.11.027","volume":"40","author":"S Venkat","year":"2022","unstructured":"Venkat S, Khan AI, Lewicki PJ, et al. Novel nomograms to predict muscle invasion and lymph node metastasis in upper tract urothelial carcinoma. Urol Oncol. 2022;40(3):108.e11-108.e17.","journal-title":"Urol Oncol"},{"issue":"6","key":"15554_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.urolonc.2022.10.024","volume":"41","author":"W Wang","year":"2023","unstructured":"Wang W, Li W, Wang K, et al. Integrating radiomics with the vesical imaging-reporting and data system to predict muscle invasion of bladder cancer. Urol Oncol. 2023;41(6):294. .e1-294.e8.","journal-title":"Urol Oncol"},{"issue":"9","key":"15554_CR26","doi-asserted-by":"publisher","first-page":"5845","DOI":"10.1245\/s10434-024-15760-5","volume":"31","author":"M \u015eam \u00d6zdemir","year":"2024","unstructured":"\u015eam \u00d6zdemir M, Azamat S, \u00d6zdemir H, et al. Preoperative prediction of muscle invasiveness in bladder cancer: the role of 3D volumetric radiomics using Diffusion-Weighted MRI, the VI-RADS Score, or a combination of both. Ann Surg Oncol. 2024;31(9):5845\u201350. https:\/\/doi.org\/10.1245\/s10434-024-15760-5.","journal-title":"Ann Surg Oncol"},{"issue":"1145","key":"15554_CR27","doi-asserted-by":"publisher","first-page":"20221086","DOI":"10.1259\/bjr.20221086","volume":"96","author":"X Fan","year":"2023","unstructured":"Fan X, Yu H, Ni X, et al. Systematic radiomics analysis based on multiparameter MRI to preoperatively predict the expression of Ki67 and histological grade in patients with bladder cancer. Br J Radiol. 2023;96(1145):20221086. https:\/\/doi.org\/10.1259\/bjr.20221086.","journal-title":"Br J Radiol"},{"key":"15554_CR28","doi-asserted-by":"publisher","unstructured":"Zhang M, Zhao Y, Hao D et al. An interpretable CT-based deep learning model for predicting overall survival in patients with bladder cancer: a multicenter study. NPJ Precis Oncol. 2025;9(1):288. Published 2025 Aug 16. https:\/\/doi.org\/10.1038\/s41698-025-01083-5.","DOI":"10.1038\/s41698-025-01083-5"},{"issue":"5","key":"15554_CR29","doi-asserted-by":"publisher","first-page":"3260","DOI":"10.1007\/s00330-021-08426-3","volume":"32","author":"G Zhang","year":"2022","unstructured":"Zhang G, Wu Z, Zhang X, et al. CT-based radiomics to predict muscle invasion in bladder cancer. Eur Radiol. 2022;32(5):3260\u20138. https:\/\/doi.org\/10.1007\/s00330-021-08426-3.","journal-title":"Eur Radiol"},{"issue":"5","key":"15554_CR30","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1097\/JS9.0000000000001194","volume":"110","author":"Z Wei","year":"2024","unstructured":"Wei Z, Xv Y, Liu H, et al. A CT-based deep learning model predicts overall survival in patients with muscle invasive bladder cancer after radical cystectomy: a multicenter retrospective cohort study. Int J Surg. 2024;110(5):2922\u201332. https:\/\/doi.org\/10.1097\/JS9.0000000000001194. Published 2024 May 1.","journal-title":"Int J Surg"},{"issue":"11","key":"15554_CR31","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.acra.2022.02.007","volume":"29","author":"S Evrimler","year":"2022","unstructured":"Evrimler S, Ali Gedik M, Ahmet Serel T, et al. Bladder urothelial carcinoma: machine Learning-based computed tomography radiomics for prediction of histological variant. Acad Radiol. 2022;29(11):1682\u20139. https:\/\/doi.org\/10.1016\/j.acra.2022.02.007.","journal-title":"Acad Radiol"},{"key":"15554_CR32","doi-asserted-by":"publisher","first-page":"107466","DOI":"10.1016\/j.cmpb.2023.107466","volume":"233","author":"J Li","year":"2023","unstructured":"Li J, Qiu Z, Cao K, et al. Predicting muscle invasion in bladder cancer based on MRI: A comparison of radiomics, and single-task and multi-task deep learning. Comput Methods Programs Biomed. 2023;233:107466. https:\/\/doi.org\/10.1016\/j.cmpb.2023.107466.","journal-title":"Comput Methods Programs Biomed"},{"issue":"6","key":"15554_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.urolonc.2025.01.007","volume":"43","author":"P Russo","year":"2025","unstructured":"Russo P, Foschi N, Palermo G, et al. SIRI as a biomarker for bladder neoplasm: utilizing decision curve analysis to evaluate clinical net benefit. Urol Oncol. 2025;43(6):393.e1-393.e8.","journal-title":"Urol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15554-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15554-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15554-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:05:16Z","timestamp":1771542316000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15554-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,19]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15554"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15554-w","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,19]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study and related projects have been approved by the Biomedical Research Ethics Committees of the Second Affiliated Hospital of Nanchang University, Jiangxi Provincial People\u2019s Hospital, and the First Affiliated Hospital of Nanchang University, with all committees waiving the requirement for informed consent. All procedures were conducted in accordance with relevant guidelines and regulations. This study fully complies with the Declaration of Helsinki (\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"278"}}